Page 19 - Read Online

Page 10 of 14 Di Raimo et al. J Cancer Metastasis Treat 2018;4:54 I http://dx.doi.org/10.20517/2394-4722.2018.50

33. Goodman CR, Seagle BL, Friedl TWP, Rack B, Lato K, et al. Association of circulating tumor cell status with benefit of radiotherapy and
survival in early-stage breast cancer. JAMA Oncol 2018;4:e180163.
34. Giuliano M, Shaikh A, Lo HC, Arpino G, De Placido S, et al. Perspective on circulating tumor cell clusters: why it takes a village to
metastasize. Cancer Res 2018;78:845-52.
35. Rossi G, Mu Z, Rademaker AW, Austin LK, Strickland KS, et al. Cell-free DNA and circulating tumor cells: comprehensive liquid biopsy
analysis in advanced breast cancer. Clin Cancer Res 2018;24:560-8.
36. Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, et al. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic
breast cancer. Breast Cancer Res Treat 2017;161:83-94.
37. Mu Z, Benali-Furet N, Uzan G, Znaty A, Ye Z, et al. Detection and characterization of circulating tumor associated cells in metastatic breast
cancer. Int J Mol Sci 2016;17:E1665.
38. Dawood S, Cristofanilli M. Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies? Pharmacogenomics
2015;16:669-72.
39. Giuliano M, Giordano A, Jackson S, De Giorgi U, Mego M, et al. Circulating tumor cells as early predictors of metastatic spread in breast
cancer patients with limited metastatic dissemination. Breast Cancer Res 2014;16:440.
40. Cristofanilli M. Circulating tumour cells: telling the truth about metastasis. Lancet Oncol 2014;15:365-6.
41. Jiang ZF, Cristofanilli M, Shao ZM, Tong ZS, Song EW, et al. Circulating tumor cells predict progression-free and overall survival in
Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial.
Ann Oncol 2013;24:2766-72.
42. Cristofanilli M, Fortina P. Circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013;369:93.
43. Dong X, Alpaugh KR, Cristofanilli M. Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular
analysis. Chin J Cancer Res 2012;24:388-98.
44. Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol 2018;25:1783-5.
45. Stone RC, Pastar I, Ojeh N, Chen V, Liu S, et al. Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell Tissue Res
2016;365:495-506.
46. Forte E, Chimenti I, Rosa P, Angelini F, Pagano F, et al. EMT/MET at the crossroad of stemness, regeneration and oncogenesis: the Ying-
Yang equilibrium recapitulated in cell spheroids. Cancers (Basel) 2017;9:E98.
47. Roche J. The Epithelial-to-mesenchymal transition in cancer. Cancers (Basel) 2018;10.
48. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
49. Gos M, Miłoszewska J, Przybyszewska M. Epithelial-mesenchymal transition in cancer progression. Postepy Biochem 2009;55:121-8.
50. Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol
2012;22:194-207.
51. Lowes LE, Allan AL. Circulating tumor cells and implications of the epithelial-to-mesenchymal transition. Adv Clin Chem 2018;83:121-81.
52. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009;19:156-72.
53. Derynck R, Muthusamy BP, Saeteurn KY. Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. Curr Opin
Cell Biol 2014;31:56-66.
54. Petrova YI, Schecterson L, Gumbiner BM. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell 2016;27:3233-44.
55. Phillips S, Kuperwasser C. SLUG: critical regulator of epithelial cell identity in breast development and cancer. Cell Adh Migr
2014;8:578-87.
56. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor
progression. J Mammary Gland Biol Neoplasia 2010;15:117-34.
57. Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, et al. EMT-activating transcription factors in cancer: beyond EMT and tumor
invasiveness. Cell Mol Life Sci 2012;69:3429-56.
58. Godde NJ, Galea RC, Elsum IA, Humbert PO. Cell polarity in motion: redefining mammary tissue organization through EMT and cell
polarity transitions. J Mammary Gland Biol Neoplasia 2010;15:149-68.
59. Gloushankova NA, Rubtsova SN, Zhitnyak IY. Cadherin-mediated cell-cell interactions in normal and cancer cells. Tissue Barriers
2017;5:e1356900.
60. Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, et al. Heterogeneous atypical cell populations are present in blood
of metastatic breast cancer patients. Breast Cancer Res 2014;16:R23.
61. Bredemeier M, Edimiris P, Mach P, Kubista M, Sjöback R, et al. Gene Expression Signatures in Circulating Tumor Cells Correlate with
Response to Therapy in Metastatic Breast Cancer. Clin Chem 2017;63:1585-93.
62. Ušiaková Z, Mikulová V, Pintérová D, Brychta M, Valchář J, et al. Circulating tumor cells in patients with breast cancer: monitoring
chemotherapy success. In Vivo 2014;28:605-14.
63. Yan WT, Cui X, Chen Q, Li YF, Cui YH, et al. Circulating tumor cell status monitors the treatment responses in breast cancer patients: a
meta-analysis. Sci Rep 2017;7:43464.
64. Hensler M, Vančurová I, Becht E, Palata O, Strnad P, et al. Gene expression profiling of circulating tumor cells and peripheral blood
mononuclear cells from breast cancer patients. Oncoimmunology 2016;5:e1102827.
65. Markiewicz A, Książkiewicz M, Wełnicka-Jaśkiewicz M, Seroczyńska B, Skokowski J, et al. Mesenchymal phenotype of CTC-enriched
blood fraction and lymph node metastasis formation potential. PLoS One 2014;9:e93901.
66. Lasa A, Garcia A, Alonso C, Millet P, Cornet M, et al. Molecular detection of peripheral blood breast cancer mRNA transcripts as a
surrogate biomarker for circulating tumor cells. PLoS One 2013;8:e74079.
67. Molloy TJ, Devriese LA, Helgason HH, Bosma AJ, Hauptmann M, et al. A multimarker QPCR-based platform for the detection of
circulating tumour cells in patients with early-stage breast cancer. Br J Cancer 2011;104:1913-9.
68. Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, et al. Assessment of a six gene panel for the molecular detection of